Skip to main content

Divi's Laboratories

Divi's Laboratories Limited is an Indian pharmaceutical manufacturer specializing in active pharmaceutical ingredients (APIs) and intermediate compounds. The company operates through two core business areas: Generic APIs and Custom Synthesis for innovator biopharmaceutical companies. Its product lines encompass active ingredients for anti-inflammatory treatments, nutraceutical carotenoids, and complex chemical intermediates. Revenue is generated through the export and direct sale of high-volume APIs and proprietary contract synthesis services to global pharmaceutical players. Divi's Laboratories holds a leading global market position as a top producer of active ingredients such as Naproxen and Dextromethorphan. The company is headquartered in Hyderabad, India, and its shares are listed on the National Stock Exchange of India and BSE Limited.

21 of the funds FundTelligence covers report a position in Divi's Laboratories.

Legal name
Divi's Laboratories Ltd
Sector
Health Care
Country
India
Funds holding it
21

Funds holding Divi's Laboratories

Showing the 8 largest of 21 funds holding it.

Loading...